Study guide
13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
NBCRNA CRNA Certified Registered Nurse Anesthetist NCE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology
1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders
2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems
2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms
3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives
3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology
4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics
4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics
5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies
5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout
6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators
6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging
7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation
7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways
8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety
8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety
9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation
9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication
10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring
10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies
11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms
11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)
12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA
12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm
13 Chapter 13: Regional Anesthesia: Neuraxial Blocks
13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance
14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols
15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice
15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives
16 Chapter 16: Obstetric & Gynecologic Anesthesia
16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient
17 Chapter 17: Pediatric Anesthesia
17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm
18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia
18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols
19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia
19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction
20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia
20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation
21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology
21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements
22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology
22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices
23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures
23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases
24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control
24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure
25 Chapter 25: Neurosurgical Subspecialty Procedures
25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy
26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia
26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery
27 Chapter 27: Orthopedic & Extremity Anesthesia
27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block
28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy
28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia
29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients
29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient
13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
Key Takeaways Explain This Topic AI
The American Society of Regional Anesthesia and Pain Medicine (ASRA) guidelines establish strict withholding intervals for neuraxial instrumentation and catheter manipulation/removal to prevent catastrophic spinal epidural hematoma.
Unfractionated Heparin (UFH): Subcutaneous prophylaxis (5000 U bid/tid) requires no mandatory hold time; therapeutic IV heparin requires a 4-6 hour hold with documentation of normal aPTT before puncture/removal, and waiting ≥1 hour after puncture before systemic heparin administration.
Low Molecular Weight Heparin (LMWH): Prophylactic dosing (e.g. Enoxaparin 40 mg daily) mandates a 12-hour hold prior to puncture/catheter removal; therapeutic dosing (e.g. Enoxaparin 1 mg/kg q12h) mandates a 24-hour hold; restart LMWH ≥4 hours after catheter removal.
Direct Oral Anticoagulants (DOACs) require holding Rivaroxaban/Apixaban for 72 hours and Dabigatran for 72-120 hours; Warfarin requires holding for 5 days with documentation of a normal INR (<1.4-1.5); Clopidogrel requires a 5-7 day hold, whereas Aspirin alone requires no discontinuation.
Spinal Epidural Hematoma (SEH) is a surgical emergency presenting with sharp back pain, motor/sensory block progression, and bowel/bladder dysfunction; emergent MRI and decompressive laminectomy within 6 to 8 hours of symptom onset is mandatory to prevent permanent, irreversible paraplegia.
Last updated: August 2026
13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
Performing neuraxial procedures in the presence of altered hemostasis introduces the catastrophic risk of Spinal Epidural Hematoma (SEH) . Because the vertebral canal is a rigid, non-distensible bony ring, an expanding hematoma compresses spinal cord blood flow and neural tissue, causing permanent ischemic paraplegia unless surgically decompressed within hours. Strict adherence to the American Society of Regional Anesthesia and Pain Medicine (ASRA) anticoagulation guidelines is mandatory.
1. ASRA Anticoagulation Consensus Guidelines: Comprehensive Matrix +---------------------------------------------------------------------------------------------------------+
- | ASRA NEURAXIAL ANTICOAGULATION GUIDELINES |
- +-----------------------+-----------------------------+-----------------------------+---------------------+
- | Drug Class & Name | Pre-Procedure Discontinuation| Catheter Removal Timing | Post-Removal Restart|
- | | (Hold Time Before Puncture) | (Hold Time Before Pulling) | (Wait Time to Dose) |
- +-----------------------+-----------------------------+-----------------------------+---------------------+
- | **SubQ UFH Prophylaxis| **No mandatory delay** | **No mandatory delay** | May dose immediately|
- | (5,000 U bid or tid) | (Check platelets if >4 days)| (Avoid pulling at peak 2h) | after catheter pull |
- +-----------------------+-----------------------------+-----------------------------+---------------------+
- | **IV Heparin** | **4 - 6 hours** | **4 - 6 hours** | **≥ 1 hour** |
- | (Therapeutic Infusion)| + Document NORMAL aPTT/ACT | + Document NORMAL aPTT/ACT | (Wait ≥1h post-op) |
- +-----------------------+-----------------------------+-----------------------------+---------------------+
- | **LMWH Prophylactic** | **12 hours** | **12 hours** | **≥ 4 hours** |
- | (Enoxaparin 40 mg q24h| (Enoxaparin, Dalteparin) | (Delay dose until removed) | |
- +-----------------------+-----------------------------+-----------------------------+---------------------+
- | **LMWH Therapeutic** | **24 hours** | **24 hours** | **≥ 4 hours** |
- | (Enoxaparin 1 mg/kg) | (Full treatment dose) | (No indwelling cath with bid)| (≥24h if major surg)|
- +-----------------------+-----------------------------+-----------------------------+---------------------+
- | **Warfarin** | **5 days** | **Document INR < 1.4 - 1.5**| Immediate post-pull |
- | (Coumadin) | + Document INR < 1.4 - 1.5 | before pulling catheter | |
- +-----------------------+-----------------------------+-----------------------------+---------------------+
- | **Rivaroxaban / | **72 hours** (3 days) | **72 hours** | **≥ 6 hours** |
- | Apixaban (Xa Inh)** | | | |
- +-----------------------+-----------------------------+-----------------------------+---------------------+
- | **Dabigatran** | **72 hours** (CrCl ≥ 50) | **72 hours** (CrCl ≥ 50) | **≥ 6 hours** |
- | (Direct Thrombin Inh) | **120 hours** (CrCl 30-49) | **120 hours** (CrCl 30-49) | |
- +-----------------------+-----------------------------+-----------------------------+---------------------+
- | **Clopidogrel** | **5 - 7 days** | **5 - 7 days** | Immediate (no load);|
- | (Plavix - P2Y12) | (5 days minimum) | | ≥6h if 300-600mg ld |
- +-----------------------+-----------------------------+-----------------------------+---------------------+
- | **Prasugrel** (Effient)| **7 - 10 days** | **7 - 10 days** | **≥ 6 hours** |
- | **Ticagrelor**(Brilinta)| **3 - 5 days** | **3 - 5 days** | **≥ 6 hours** |
- +-----------------------+-----------------------------+-----------------------------+---------------------+
- | **Aspirin / NSAIDs** | **NO mandatory hold** | **NO mandatory hold** | No restriction |
- | (Monotherapy) | (Safe as single agent) | (Safe as single agent) | |
- +-----------------------+-----------------------------+-----------------------------+---------------------+
- | **GP IIb/IIIa Inh** | • Abciximab: **24-48 hrs** | • Abciximab: **24-48 hrs** | Immediate post-pull |
- | | • Eptifibatide: **4-8 hrs** | • Eptifibatide: **4-8 hrs** | |
- +-----------------------+-----------------------------+-----------------------------+---------------------+
- | **Thrombolytics** | **10 days** | **10 days** | Absolute contraindic|
- | (tPA, Alteplase) | | | during infusion |
- +-----------------------+-----------------------------+-----------------------------+---------------------+
- | **Herbal Supplements**| **NO mandatory hold** | **NO mandatory hold** | No restriction |
- | (Garlic, Ginkgo, Gins)| (Monitor if combined) | (Monitor if combined) | |
- +-----------------------+-----------------------------+-----------------------------+---------------------+
- Special Clinical Scenarios in Neuraxial Anticoagulation
Intraoperative Systemic Heparinization (e.g., Vascular / Cardiac Surgery):
Neuraxial needle placement or catheter insertion must occur at least ≥ 1 hour \ge 1 \text{ hour} ≥ 1 hour before systemic heparin administration .
If a bloody or traumatic tap occurs, consider postponing surgery for 24 hours 24 \text{ hours} 24 hours ; if surgery cannot be delayed, monitor postoperative neurological status with extreme vigilance.
Warfarin Initiated with Indwelling Epidural Catheter:
Monitor INR daily. Catheter removal is permitted when INR < 1.4 − 1.5 \text{INR} < 1.4 - 1.5 INR < 1.4 − 1.5 .
If the INR is 1.5 − 3.0 1.5 - 3.0 1.5 − 3.0 , withhold warfarin and conduct hourly neurologic exams until INR declines below 1.4 1.4 1.4 .
If the INR > 3.0 >3.0 > 3.0 , withhold warfarin, reverse with Vitamin K or Prothrombin Complex Concentrate (PCC) if emergent removal is required.
2. Spinal Epidural Hematoma (SEH): Etiology & Pathophysiology [SPINAL EPIDURAL HEMATOMA PATHOGENESIS]
- Needle / Catheter Trauma to Batson's Internal Venous Plexus
- |
- v
- Impaired Hemostasis / Peak Anticoagulant Pharmacokinetics
- |
- v
- Expanding Space-Occupying Mass in Rigid Bony Spinal Canal
- |
- v
- Tissue Pressure Exceeds Spinal Cord Venous & Capillary Pressure
- |
- +--------------------------+--------------------------+
- | |
- v v
- Direct Mechanical Neural Compression Spinal Cord Ischemia & Necrosis
- Cauda equina root flattening • Anterior spinal artery hypoperfusion
- Flaccid lower motor neuron paralysis • Venous infarction of spinal cord
- | |
- +--------------------------+--------------------------+
- |
- v
- THE CLASSICAL CLINICAL TRIAD OF EPIDURAL HEMATOMA
- 1. Sharp, severe, unremitting back pain (± radicular pain)
- 2. Progressive motor weakness & sensory deficit (flaccid paraplegia)
- 3. Sphincter dysfunction (urinary retention & fecal incontinence)
- Major Risk Factors for Spinal Epidural Hematoma
Pharmacologic: Neuraxial instrumentation during peak anticoagulant effect, concurrent multi-agent anticoagulation (e.g., NSAID + LMWH + antiplatelet), or premature catheter removal.
Patient Factors: Advanced age ( > 65 >65 > 65 years), female gender, preexisting spinal canal stenosis, ankylosing spondylitis, severe scoliosis, chronic renal failure (drug accumulation).
Procedural Factors: Multiple needle attempts, difficult/traumatic "bloody tap", large-bore needles (17G Tuohy), and catheter removal (which carries equal risk to initial catheter placement).
3. SEH Diagnostic Emergency & The Critical 6 to 8 Hour Window +-------------------------------------------------------------------------+
- | EPIDURAL HEMATOMA EMERGENCY ACTION PROTOCOL |
- +-------------------------------------------------------------------------+
- | |
- | STEP 1: Immediate Clinical Recognition & Local Anesthetic Cessation |
- | • Immediately STOP any epidural local anesthetic infusion |
- | • Do NOT assume block prolongation is simply delayed drug clearance |
- | • Perform immediate focused motor, sensory, and rectal sphincter exams|
- | |
- | STEP 2: STAT Diagnostic Imaging (Gold Standard) |
- | • Order an **EMERGENT STAT MRI of the Spine** (without/with contrast) |
- | • If MRI is contraindicated (pacemaker/metal), perform STAT CT |
- | Myelography |
- | |
- | STEP 3: Emergent Neurosurgical / Spine Consultation |
- | • Alert spine surgery team while the patient is en route to MRI |
- | • Prepare patient for immediate operating room transfer |
- | |
- | STEP 4: Emergent Surgical Decompression (The 6-8 Hour Rule) |
- | • Perform **Decompressive Laminectomy and Hematoma Evacuation** |
- | • **Time Window: MUST occur within 6 to 8 hours of symptom onset** |
- | • Decompression within 6-8 hrs yields >80-90% neurological recovery |
- | • Decompression delayed >8-12 hrs results in permanent, irreversible |
- | flaccid paraplegia and permanent loss of bowel/bladder control |
+-------------------------------------------------------------------------+ [SURGICAL DECOMPRESSION TIMELINE & OUTCOMES]
- Neurologic
- Recovery (%)
- 100 | /-------------------\
- 80 | / \
- 60 |/ \
- 40 | \
- 20 | \
- 0 +---------------------------+---------------------------+-----> Time to Laminectomy
- 0 6 12 (Hours)
- <==== EXCELLENT RECOVERY ====> <== PERMANENT PARAPLEGIA ==>
- (0 to 6-8 Hours) (>8 to 12 Hours)
4. Differential Diagnosis: Epidural Hematoma vs. Epidural Abscess +-------------------------------------------------------------------------+
- | EPIDURAL HEMATOMA vs. EPIDURAL ABSCESS vs. MENINGITIS |
- +--------------------+------------------------+---------------------------+
- | Clinical Domain | Spinal Epidural | Spinal Epidural |
- | | Hematoma (SEH) | Abscess (SEA) |
- +--------------------+------------------------+---------------------------+
- | **Etiology** | Venous / arterial | Bacterial infection |
- | | hemorrhage in canal | (*Staph aureus* 60-70%) |
- | **Primary Risk** | Anticoagulants, | Prolonged catheter (>3d), |
- | | coagulopathy, trauma | immunosuppression, sepsis |
- | **Onset Speed** | **Hyperacute / Sudden**| **Subacute / Indolent** |
- | | (Hours after block/pull| (2 to 7 days post-op) |
- | **Temperature / | Afebrile; normal WBC | **Fever, severe chills, |
- | Systemic Signs** | | leukocytosis, ↑ ESR / CRP |
- | **Classical Signs**| Acute severe back pain,| 4 Stages: Backache → |
- | | motor/sensory block, | Radicular pain → Motor/ |
- | | bowel/bladder loss | sensory loss → Paraplegia |
- | **Diagnostic Test**| STAT Spine MRI | STAT Spine MRI + Contrast |
- | **Definitive Rx** | Emergent laminectomy | IV Vancomycin + Cefepime; |
- | | within **6 - 8 hours** | Surgical drainage/decomp. |
- +--------------------+------------------------+---------------------------+
NCE Board Golden Rule — Unexplained Motor Block Prolongation: Any motor or sensory block that worsens, ascends, or fails to regress within the expected pharmacologic duration of the administered local anesthetic is a Spinal Epidural Hematoma until proven otherwise . Never wait for full recovery or attribute findings to local anesthetic variability—stop infusions and obtain a STAT MRI immediately.